Menu

Randy Schekman to Leave eLife

The founding editor-in-chief will redirect his focus to a Parkinson’s organization.

Aug 19, 2018
Kerry Grens

ABOVE: FLICKR, 2014 ELIFE SCIENCES PUBLICATIONS LTD

Come next year, Randy Schekman will no longer be at the helm of eLife, the journal he launched six years ago, according to a statement. The Nobel laureate will instead devote his efforts to Aligning Science Across Parkinson’s, an organization that is developing research strategies for diagnostics, biomarkers, and therapies.

Schekman, a cell and molecular biologist at the University of California, Berkeley, has been a vocal critic of traditional science publishing for years, even vowing to boycott the high-profile journals where he had reported his Nobel-winning work on vesicle trafficking. Before starting eLife, he served as the editor-in-chief of PNAS. When the opportunity came in 2012 to start fresh with a new publication, Schekman decided to change the way the process was done—making peer reviewers collaborate, using working scientists as editors, shortening the time to publication, and presenting all papers open access. At the beginning, eLife was able to entice submissions by waiving the fees.

eLife has now become a popular online journal. In 2016, for instance, it published for the first time more than 1,000 papers in a year.

Most recently, Schekman and his colleagues at eLife introduced a trial of a new peer-review format in which the journal commits to publishing a paper once the editor has decided to send it out for peer review. Then, both the reviewers’ report and the authors’ response and revised article are published.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.